BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its Chief Medical Officer, Dr. Mark Bagarazzi, will present at the Cancer Immunotherapy: A Long-Awaited Reality conference on Thursday, October 21, 2010, at the New York Academy of Medicine,1216 5th Ave. (at 103rd St.) New York, NY.
